Genomic Health

Genomic Health Genomic Health, Inc. is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring. The company is based in Redwood City, California, with European headquarters in Geneva, Switzerland.
Type
Public
HQ
Redwood City, US
Founded
2000
Size (employees)
802 (est)
Genomic Health was founded in 2000 and is headquartered in Redwood City, US

Genomic Health Office Locations

Genomic Health has an office in Redwood City
Redwood City, US (HQ)
101 Galveston Dr

Genomic Health Data and Metrics

Genomic Health Financial Metrics

Genomic Health's revenue was reported to be $327.9 m in 2016
Numbers are in $, USD

Revenue (Y, 2016)

327.9 m

Revenue growth (Y, 2015 - Y, 2016), %

14%

Net income (Y, 2016)

(13.9 m)

EBIT (Y, 2016)

(15.4 m)

Market capitalization (25-May-2017)

1 b

Closing share price (25-May-2017)

29

Cash (31-Dec-2016)

40.4 m
Genomic Health's current market capitalization is $1 b.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015Y, 2016

Revenue

261.6 m275.7 m287.5 m327.9 m

Revenue growth, %

5%4%14%

Gross profit

219.5 m227 m233.7 m

Gross profit Margin, %

84%82%81%

Operating expense total

231.3 m250.6 m267.7 m343.3 m

EBIT

(11.8 m)(23.6 m)(34 m)(15.4 m)

EBIT margin, %

(5%)(9%)(12%)(5%)

Interest income

222 k192 k221 k418 k

Pre tax profit

(12.4 m)(24.2 m)(34.3 m)(12.5 m)

Income tax expense

346 k393 k(996 k)1.4 m

Net Income

(12.8 m)(24.6 m)(33.3 m)(13.9 m)
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

33.3 m29.7 m32.5 m40.4 m

Accounts Receivable

29.4 m34.9 m37.2 m35.2 m

Inventories

10.2 m9.9 m10.8 m13.8 m

Current Assets

145 m148.5 m143 m146 m

PP&E

18.3 m21.9 m39.7 m45.7 m

Total Assets

177 m185.9 m184.6 m201.1 m

Accounts Payable

5.2 m7 m8.6 m2.9 m

Current Liabilities

29.8 m38.3 m42.7 m41.2 m

Additional Paid-in Capital

345.3 m370.5 m

Retained Earnings

(170.3 m)(194.9 m)(228.2 m)(242.1 m)

Total Equity

145 m145.5 m139.5 m156.1 m

Financial Leverage

1.2 x1.3 x1.3 x1.3 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(12.8 m)(24.6 m)(33.3 m)(13.9 m)

Depreciation and Amortization

6.3 m7.1 m8.9 m

Accounts Receivable

(7.2 m)34.9 m(2.2 m)2 m

Inventories

9.9 m

Accounts Payable

1.2 m7 m949 k(4.6 m)

Cash From Operating Activities

8.6 m(3.6 m)(11.8 m)13.5 m

Purchases of PP&E

(11 m)(23.5 m)(19.8 m)

Cash From Investing Activities

(7 m)6.3 m(19.1 m)

Cash From Financing Activities

13.7 m8.4 m13.5 m

Income Taxes Paid

336 k459 k428 k
Y, 2016

Financial Leverage

1.3 x

Genomic Health Market Value History

Genomic Health Median Salaries

Source: 29 public H-1B filings from Genomic Health

Genomic Health Online and Social Media Presence

Genomic Health News and Updates

Genomic Health Company Life and Culture

You may also be interested in